Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors

Clinical trial NCT07688356 · RECRUITING

Trial details

NCT number: NCT07688356
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Brain Tumor Metastatic Brain Tumor

Start date: 2026-06-15
Primary completion: 2028-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.